Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Leboyer

Showing results (471-480 of 549) with videos related to

Pageof 55
Sort By:
Journal of Psychosomatic Research|June 25, 2025
Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ)Rudy Tokarski, Susana Barbosa, Baptiste Pignon, et al.
Brain Sciences|December 16, 2020
Treatment-Resistant Depression in a Real-World Setting: First Interim Analysis of Characteristics, Healthcare Resource Use, and Utility Values of the FondaMental CohortAntoine Yrondi, Djamila Bennabi, Emmanuel Haffen, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 21, 2022
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophreniaThéo Korchia, Maud Tastevin, Pierre-Louis Sunhary de Verville, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 8, 2016
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant responseChiara Fabbri, Ladislav Hosak, Rainald Mössner, et al.
Brain, Behavior, & Immunity - Health|October 6, 2025
Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis studyFrancisca Silva, Andrei Szöke, Mohamed Lajnef, et al.
American Journal of Human Genetics|April 17, 2012
SHANK1 Deletions in Males with Autism Spectrum DisorderDaisuke Sato, Anath C Lionel, Claire S Leblond, et al.
Psychiatry Research|June 3, 2025
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohortKaori Saitoh, Mohamed Lajnef, Wahid Boukouaci, et al.
Bipolar Disorders|March 9, 2023
Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depressionChiara C Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, et al.
Scientific Reports|October 17, 2023
Maternal immune activation during pregnancy is associated with more difficulties in socio-adaptive behaviors in autism spectrum disorderPierre Ellul, Anna Maruani, Valérie Vantalon, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Pageof 55

Showing results (471-480 of 549) with videos related to

Sort By:
Pageof 55
Journal of Psychosomatic Research|June 25, 2025
Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ)Rudy Tokarski, Susana Barbosa, Baptiste Pignon, et al.
Brain Sciences|December 16, 2020
Treatment-Resistant Depression in a Real-World Setting: First Interim Analysis of Characteristics, Healthcare Resource Use, and Utility Values of the FondaMental CohortAntoine Yrondi, Djamila Bennabi, Emmanuel Haffen, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 21, 2022
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophreniaThéo Korchia, Maud Tastevin, Pierre-Louis Sunhary de Verville, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 8, 2016
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant responseChiara Fabbri, Ladislav Hosak, Rainald Mössner, et al.
Brain, Behavior, & Immunity - Health|October 6, 2025
Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis studyFrancisca Silva, Andrei Szöke, Mohamed Lajnef, et al.
American Journal of Human Genetics|April 17, 2012
SHANK1 Deletions in Males with Autism Spectrum DisorderDaisuke Sato, Anath C Lionel, Claire S Leblond, et al.
Psychiatry Research|June 3, 2025
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohortKaori Saitoh, Mohamed Lajnef, Wahid Boukouaci, et al.
Bipolar Disorders|March 9, 2023
Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depressionChiara C Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, et al.
Scientific Reports|October 17, 2023
Maternal immune activation during pregnancy is associated with more difficulties in socio-adaptive behaviors in autism spectrum disorderPierre Ellul, Anna Maruani, Valérie Vantalon, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Pageof 55